Side-by-side comparison of AI visibility scores, market position, and capabilities
Affordable cord blood and tissue banking with FDA-registered storage for broader stem cell access; $4.62M from Seven Seven Six and YC at $1.8M revenue competing with CBR for expectant parent insurance market.
Anja Health is a San Jose-based cord blood and cord tissue banking company that makes stem cell preservation from newborn births accessible and affordable — providing nationwide FDA-registered collection and storage of umbilical cord blood and cord tissue that contain hematopoietic stem cells and mesenchymal stem cells, which may be used in future treatments for blood disorders, immune conditions, and emerging regenerative medicine applications. Founded in 2021 and backed by Alexis Ohanian's Seven Seven Six fund and Y Combinator with $4.62 million raised including a $2 million seed round in May 2024, Anja Health achieved $1.8 million in revenue as of December 2024.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.